Unlock AI-driven, actionable R&D insights for your next breakthrough.

Biodegradable Polyglycolic Acid: Comprehensive Analysis Of Synthesis, Properties, And Advanced Applications

MAR 25, 202668 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Biodegradable polyglycolic acid (PGA), also known as polyglycolide, represents the simplest linear aliphatic polyester with exceptional biodegradability, mechanical strength, and gas barrier properties. As a thermoplastic polymer derived from glycolic acid through polycondensation or ring-opening polymerization of glycolide, PGA has emerged as a critical material in medical devices, packaging applications, and environmental sustainability initiatives. This comprehensive analysis explores the molecular architecture, synthesis pathways, degradation mechanisms, and expanding industrial applications of biodegradable polyglycolic acid, providing research professionals with actionable insights for product development and process optimization.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Structure And Fundamental Characteristics Of Biodegradable Polyglycolic Acid

Biodegradable polyglycolic acid is characterized by its simple repeating unit structure: [-O-CH₂-CO-]ₙ, where n represents the degree of polymerization 2. This linear aliphatic polyester exhibits a highly regular molecular architecture that facilitates crystalline domain formation, typically achieving crystallinity levels between 40-80% 15. The polymer's melting point ranges from 215°C to 225°C for homopolymers, though this value varies depending on synthesis conditions, thermal history, and molecular weight distribution 3. The presence of ester linkages (-COO-) in the backbone imparts hydrolytic instability, which is fundamental to PGA's biodegradability profile 1.

The molecular weight of biodegradable polyglycolic acid critically determines its mechanical performance and processability. High-molecular-weight PGA (Mw > 20,000 Da) can be drawn into fibrous forms with directional molecular alignment, significantly enhancing tensile strength and making it suitable for demanding applications such as surgical sutures and fracture fixation materials 15. When the average molecular weight reaches 20,000-145,000 Da, the polymer exhibits sufficient strength for load-bearing medical implants while maintaining biodegradability 15. However, achieving such high molecular weights through direct polycondensation of glycolic acid remains challenging, necessitating alternative synthesis routes 2.

The crystalline structure of biodegradable polyglycolic acid contributes to its exceptional gas barrier properties, particularly against oxygen, carbon dioxide, and water vapor 6. This characteristic, combined with mechanical robustness, positions PGA as a superior alternative to conventional petroleum-based packaging materials. The polymer's solubility profile is highly selective: it remains insoluble in most common organic solvents but dissolves in strong polar solvents such as hexafluoroisopropanol 15. This solvent resistance enhances its utility in applications requiring chemical stability during processing or end-use.

Synthesis Routes For Biodegradable Polyglycolic Acid Production

Polycondensation Of Glycolic Acid

Direct dehydration polycondensation of glycolic acid (α-hydroxyacetic acid) represents the most straightforward synthesis pathway for biodegradable polyglycolic acid 2. However, this method typically yields low-molecular-weight polymers (Mw < 20,000 Da) due to equilibrium limitations and side reactions 3. The process involves heating glycolic acid in the presence of tin-based catalysts (e.g., stannous octoate) to promote esterification while removing water 10. To overcome molecular weight limitations, chain extenders such as diisocyanates can be added post-condensation to increase viscosity and extend polymer chains 10. Despite these modifications, the polycondensation route remains less favored for industrial-scale production of high-performance PGA due to inferior mechanical properties compared to ring-opening polymerization products 13.

Ring-Opening Polymerization Of Glycolide

The ring-opening polymerization (ROP) of glycolide—a cyclic dimer of glycolic acid—has become the dominant industrial method for producing high-molecular-weight biodegradable polyglycolic acid 246. This process requires high-purity glycolide (>99%) as the starting material to minimize defects and abnormal linkages in the polymer chain 9. The polymerization is typically catalyzed by stannous octoate or other organometallic compounds at temperatures between 180-220°C under inert atmosphere 7. The ROP mechanism proceeds through coordination-insertion, allowing precise control over molecular weight distribution and end-group functionality 11.

Glycolide synthesis itself involves two steps: first, glycolic acid undergoes oligomerization to form low-molecular-weight oligomers; second, these oligomers are thermally depolymerized at 270-285°C under reduced pressure (1.6-2.0 kPa) to yield glycolide vapor, which is subsequently condensed and purified through recrystallization 24. Recent advances employ high-boiling-point polar organic solvents (e.g., polyalkylene glycol ethers) to dissolve oligomers during depolymerization, improving glycolide yield and reducing thermal degradation 7. The use of such solvents eliminates the need for depolymerization catalysts while suppressing side reactions that generate colored impurities 7.

Copolymerization Strategies For Property Modulation

To tailor the properties of biodegradable polyglycolic acid for specific applications, copolymerization with other cyclic monomers is widely practiced 118. Poly(lactic-co-glycolic acid) (PLGA) copolymers, with PGA:PLA ratios ranging from 85:15 to 99:1, exhibit reduced melting points and adjustable degradation rates compared to PGA homopolymers 1. Poly(glycolide-co-caprolactone) (PGACL) and poly(glycolide-co-trimethylene carbonate) (PGATMC) copolymers offer enhanced flexibility and slower hydrolysis kinetics, making them suitable for long-term drug delivery systems 118. However, increasing comonomer content beyond 15-20 mol% can compromise the gas barrier properties and crystallinity that are hallmarks of PGA 3. Therefore, copolymer design requires careful balancing of biodegradability, mechanical performance, and functional requirements.

Biodegradation Mechanisms And Environmental Fate Of Polyglycolic Acid

Biodegradable polyglycolic acid undergoes hydrolytic degradation through random scission of ester bonds in the polymer backbone when exposed to aqueous environments 116. Under physiological conditions (37°C, pH 7.4), PGA degrades via autocatalytic hydrolysis, with the rate accelerated by acidic degradation products (glycolic acid) that accumulate within the polymer matrix 18. The degradation product, glycolic acid, is non-toxic and enters the tricarboxylic acid (TCA) cycle in living organisms, where it is metabolized to water and carbon dioxide 11618. Complete resorption of PGA implants in vivo typically occurs within four to six months, though this timeframe varies with molecular weight, crystallinity, and implant geometry 118.

In natural environments such as soil and seawater, biodegradable polyglycolic acid is decomposed by microbial consortia and extracellular enzymes (e.g., esterases, lipases) 2614. The biodegradation rate depends on environmental factors including temperature, pH, microbial activity, and moisture content. Studies demonstrate that PGA films buried in compost degrade to >90% mass loss within 60-90 days at 58°C, significantly faster than polylactic acid or polycaprolactone under identical conditions 19. This rapid biodegradation profile positions PGA as an environmentally responsible alternative to persistent plastics in single-use packaging and agricultural mulch films 15.

To further accelerate degradation for specific applications (e.g., downhole tools in oil recovery), biodegradable polyglycolic acid formulations can incorporate degradation accelerators such as carboxylic anhydrides or water-soluble polymers 8. These additives enhance water uptake and catalyze ester hydrolysis, reducing degradation time to weeks rather than months 8. Conversely, for applications requiring extended service life, PGA can be blended with hydrolysis inhibitors or coated with hydrophobic layers to retard moisture ingress 3.

Thermal And Mechanical Properties Of Biodegradable Polyglycolic Acid

Thermal Behavior And Processing Windows

Biodegradable polyglycolic acid exhibits a relatively high melting point (Tm = 215-225°C) and glass transition temperature (Tg ≈ 35-40°C), reflecting its semi-crystalline nature and strong intermolecular hydrogen bonding 315. Differential scanning calorimetry (DSC) analysis reveals that PGA homopolymers display a sharp melting endotherm with crystallization enthalpy (ΔHc) ranging from 80 to 140 J/g, depending on thermal history and molecular weight 6. Thermogravimetric analysis (TGA) indicates that PGA remains thermally stable up to approximately 250°C, beyond which rapid decomposition occurs with mass loss exceeding 90% by 400°C 5.

However, biodegradable polyglycolic acid suffers from limited melt stability during processing, often generating volatile degradation products (e.g., acetaldehyde, carbon dioxide) that cause foaming and discoloration 5. To mitigate this issue, processing temperatures should be minimized (typically 230-250°C for extrusion and injection molding), and residence times in heated barrels kept below 5-10 minutes 3. The addition of thermal stabilizers such as phosphite esters or hindered phenols can suppress oxidative degradation and extend processing windows 12. Recent innovations employ reactive extrusion with chain extenders to restore molecular weight lost during melt processing, enabling production of high-quality PGA films and fibers 13.

Mechanical Performance And Anisotropy

High-molecular-weight biodegradable polyglycolic acid demonstrates impressive mechanical properties: tensile strength of 60-100 MPa, Young's modulus of 6-7 GPa, and elongation at break of 15-30% for injection-molded specimens 1517. These values surpass those of polylactic acid and polycaprolactone, making PGA particularly attractive for load-bearing applications 10. When PGA is drawn into oriented fibers (e.g., via melt spinning or electrospinning), tensile strength can exceed 800 MPa due to molecular alignment along the fiber axis 118. Such fibers are used in surgical sutures where high initial strength and controlled degradation are critical 18.

The mechanical properties of biodegradable polyglycolic acid are highly sensitive to crystallinity and molecular weight distribution. Increasing crystallinity from 40% to 70% raises the tensile modulus by approximately 50% but reduces elongation at break, rendering the material more brittle 6. Conversely, incorporating 5-15 mol% of flexible comonomers (e.g., ε-caprolactone) decreases modulus but enhances toughness and impact resistance 1. Dynamic mechanical analysis (DMA) reveals that PGA retains a storage modulus above 1 GPa at temperatures up to 150°C, indicating excellent dimensional stability under moderate thermal loads 17.

Applications Of Biodegradable Polyglycolic Acid In Medical Devices

Surgical Sutures And Wound Closure Systems

Biodegradable polyglycolic acid was the first synthetic absorbable suture material approved for clinical use, revolutionizing surgical practice in the 1960s 1314. PGA sutures (e.g., Dexon®) offer high tensile strength (>400 MPa for braided configurations), knot security, and predictable degradation kinetics, eliminating the need for suture removal 18. The polymer's hydrolytic degradation ensures that sutures lose approximately 50% of their initial strength within 2-3 weeks post-implantation, coinciding with the wound healing timeline for most soft tissues 1. Complete absorption occurs within 60-90 days, with glycolic acid metabolites excreted via the TCA cycle 16.

For enhanced performance, biodegradable polyglycolic acid sutures are often coated with biocompatible lubricants (e.g., polycaprolactone, calcium stearate) to reduce tissue drag and improve handling characteristics 18. Copolymers such as PLGA (90:10 PGA:PLA) provide slower degradation rates suitable for orthopedic and cardiovascular applications where extended mechanical support is required 1. Recent innovations include antimicrobial PGA sutures impregnated with triclosan or silver nanoparticles to reduce surgical site infections 16.

Tissue Engineering Scaffolds And Regenerative Medicine

Biodegradable polyglycolic acid scaffolds serve as temporary three-dimensional templates for cell attachment, proliferation, and differentiation in tissue engineering 11618. Electrospun PGA nanofiber meshes with fiber diameters of 200-800 nm mimic the extracellular matrix (ECM) architecture, promoting cell infiltration and neovascularization 120. These scaffolds are particularly effective for skin regeneration, where PGA's rapid degradation matches the rate of new tissue formation 16. Studies demonstrate that PGA scaffolds seeded with autologous keratinocytes and fibroblasts achieve >80% wound closure within 3 weeks in full-thickness burn models 18.

For bone and cartilage regeneration, biodegradable polyglycolic acid is often combined with bioactive ceramics (e.g., hydroxyapatite, tricalcium phosphate) to enhance osteoconductivity and mechanical strength 16. Composite scaffolds with 30-50 wt% ceramic content exhibit compressive moduli of 50-150 MPa, approaching the lower range of trabecular bone 15. The porous structure of PGA scaffolds (porosity 70-90%, pore size 100-500 μm) facilitates nutrient diffusion and waste removal, critical for cell viability in thick constructs 20. Controlled release of growth factors (e.g., BMP-2, VEGF) from PGA matrices further accelerates tissue regeneration and functional integration 16.

Drug Delivery Systems And Controlled Release Formulations

Biodegradable polyglycolic acid microparticles and nanoparticles enable sustained release of therapeutic agents over weeks to months, improving patient compliance and reducing systemic side effects 1315. PGA-based delivery systems are particularly suited for hydrophilic drugs and peptides that require protection from enzymatic degradation 10. For example, PGA microspheres (diameter 10-100 μm) loaded with insulin demonstrate near-zero-order release kinetics over 30 days in vitro, with cumulative release exceeding 85% 15. The release rate can be tuned by adjusting PGA molecular weight, particle size, and drug loading, providing flexibility for diverse therapeutic applications 13.

Copolymers such as PLGA offer additional control over release profiles by varying the PGA:PLA ratio 1. Higher PGA content accelerates degradation and drug release, while increased PLA content extends release duration 18. Biodegradable polyglycolic acid implants for localized chemotherapy (e.g., Gliadel® wafers for glioblastoma) deliver high drug concentrations directly to tumor sites while minimizing systemic toxicity 16. Emerging applications include PGA-based vaccine delivery platforms that enhance antigen presentation and immune response through sustained release of adjuvants 13.

Industrial Applications Of Biodegradable Polyglycolic Acid In Packaging And Barrier Materials

High-Barrier Films And Multilayer Structures

Biodegradable polyglycolic acid exhibits oxygen transmission rates (OTR) as low as 0.5-2.0 cm³/(m²·day·atm) at 23°C and 0% relative humidity, rivaling ethylene vinyl alcohol (EVOH) copolymers 614. This exceptional gas barrier performance stems from PGA's high crystallinity and dense molecular packing, which restrict permeant diffusion 3. PGA films with thicknesses of 20-50 μm are used in multilayer packaging structures for oxygen-sensitive products such as fresh-cut produce, processed meats, and pharmaceuticals 14. In these applications, PGA serves as the core barrier layer, sandwiched between outer layers of polylactic acid or polyethylene for moisture resistance and heat sealability 5.

Biaxial stretching of biodegradable polyglycolic acid films further enhances barrier properties and mechanical strength 5. Successively biaxially oriented PGA films (stretch ratios 3×3 to 5×5) achieve OTR values below 0.3 cm³/(m²·day·atm) and tensile strengths exceeding 150 MPa 5. However, the rapid crystallization kinetics of PGA pose challenges for stretch processing, necessitating precise temperature control (typically 60-80°C) and rapid quenching to maintain amorphous regions 5. Co-extrusion with plasticizers or low-Tg copolymers can improve stretchability without significantly compromising barrier performance [3

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
SMITH & NEPHEW PLCTissue engineering scaffolds for wound closure and skin regeneration, surgical sutures requiring high initial strength with controlled degradation matching wound healing timeline.PGA Surgical ScaffoldBiodegradable PGA fibers with >400 MPa tensile strength, complete resorption in 4-6 months via tricarboxylic acid cycle metabolism, degradation product (glycolic acid) is non-toxic and excreted as water and CO2.
KUREHA CORPORATIONMultilayer packaging structures for oxygen-sensitive products such as fresh-cut produce, processed meats and pharmaceuticals requiring superior gas barrier properties.High-Barrier PGA FilmOxygen transmission rate as low as 0.5-2.0 cm³/(m²·day·atm), biaxially oriented films achieve tensile strength exceeding 150 MPa, complete biodegradation in soil/compost within 60-90 days at 58°C.
KUREHA CORPORATIONIndustrial-scale production of medical-grade polyglycolic acid for surgical sutures, fracture fixation materials and drug delivery systems requiring high molecular weight polymers.High-Purity Glycolide Production SystemRing-opening polymerization using >99% purity glycolide yields high molecular weight PGA (Mw 20,000-145,000 Da), polyalkylene glycol ether solvent eliminates depolymerization catalysts and reduces colored impurities.
PUJING CHEMICAL INDUSTRY CO. LTDDownhole tools for oil recovery requiring accelerated degradation, packaging materials and agricultural biodegradable films, drug-controlled release systems for sustained therapeutic delivery.PGA Composite MaterialIntegrated continuous production process reduces thermal degradation, chain extender addition increases viscosity post-condensation, copolymer formulations provide adjustable mechanical properties (tensile modulus 6-7 GPa) and degradation rates.
Teknologian tutkimuskeskus VTT OyMedical implantable devices and drug delivery vehicles requiring high molecular weight with controlled crystallinity, barrier materials for packaging applications demanding mechanical strength and biodegradability.Step-Growth PGA CopolymerDiisocyanate chain extension achieves high molecular weight while maintaining crystalline structure formation, α,ω-difunctional PGA segments enable efficient step-growth polymerization with preserved thermal transitions.
Reference
  • scaffold
    PatentWO2007132186A2
    View detail
  • Glycolide production process, and glycolic acid oligomer for glycolide production
    PatentInactiveUS7235673B2
    View detail
  • Low-melt-viscosity polyglycolic acid, process for producing the same, and use of the low-melt-viscosity polyglycolic acid
    PatentInactiveEP2189486A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png